Bio-Techne (TECH) Non Operating Income (2009 - 2026)
Bio-Techne's (TECH) quarterly Non Operating Income came in at -$4.3 million in Q1 2026, down 883.87% year-on-year from $544732.5 in Q1 2025, and down 16.13% quarter-over-quarter from -$3.7 million in Q4 2025.
Bio-Techne (TECH) Non Operating Income (2009 - 2026) Analysis & Trends
Bio-Techne's Non Operating Income history runs 18 years deep, the most recent figure standing at -$4.3 million for Q1 2026.
- On a quarterly basis, Non Operating Income fell 883.87% year-over-year to -$4.3 million in Q1 2026; TTM through Mar 2026 was -$6.6 million, a 26.15% increase from a year earlier, with the FY2025 full-year figure at -$3.8 million, up 81.94% from the prior year.
- Non Operating Income declined to -$4.3 million in Q1 2026 per TECH's latest filing, from -$3.7 million in the prior quarter.
- Across five years, Non Operating Income topped out at $47.4 million in Q3 2022 and bottomed at -$21.7 million in Q1 2022.
- The 5-year median for Non Operating Income is -$3.7 million (2025), against an average of -$934470.6.
- Across the five-year window, Non Operating Income soared 1039.13% in 2022 and slumped 39326.67% in 2024, its largest moves.
- Year by year, Non Operating Income stood at -$1.5 million in 2022, then tumbled by 215.8% to -$4.6 million in 2023, then grew by 1.6% to -$4.5 million in 2024, then rose by 19.06% to -$3.7 million in 2025, then decreased by 16.13% to -$4.3 million in 2026.
- Per Business Quant, the three latest TECH Non Operating Income figures stand at -$4.3 million (Q1 2026), -$3.7 million (Q4 2025), and $333000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Bio-Techne | 11.19 Bn | 10.98 Bn | 208.29 Mn | -4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.27 Mn |
| Dec 31, 2025 | -3.68 Mn |
| Sep 30, 2025 | 333,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | -434,000.00 |
| Dec 31, 2024 | -4.54 Mn |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | -4.16 Mn |
| Mar 31, 2024 | -5.91 Mn |
| Dec 31, 2023 | -4.62 Mn |
| Sep 30, 2023 | -6.30 Mn |
| Jun 30, 2023 | -6.21 Mn |
| Mar 31, 2023 | -15,000.00 |
| Dec 31, 2022 | -1.46 Mn |
| Sep 30, 2022 | 47.40 Mn |
| Jun 30, 2022 | -1.52 Mn |
| Mar 31, 2022 | -21.68 Mn |
| Dec 31, 2021 | 23.83 Mn |
| Sep 30, 2021 | 4.16 Mn |
| Jun 30, 2021 | -61.47 Mn |